COVID-19: Expert committee approves Covaxin for children aged 2-18 years
No data on clinical trials of Bharat Biotech vaccine on children available publicly yet
COVID-19: Zydus Cadila seeks emergency approval of its needleless vaccine
This needleless vaccine, in case it gets approval, will be the world’s first plasmid deoxyribonucleic acid vaccine against COVID-19 …
COVID-19: Why ICMR okayed hydroxychloroquine as preventive med
Hydroxychloroquine has been found to be effective against SARS-CoV-2 in laboratory studies
Drug pricing body puts cap on trade margin for 42 anti-cancer drugs
Experts say move will not benefit patients as drug prices are already too high and the cap only negligible
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
COVID-19: Centre doesn’t clarify basis for CDSCO authorising remdesivir
Government also does not provide clarity about whether remdesivir should be given to only severe patients